Kazuko Matsuda's most recent trade in Medicinova Inc was a trade of 350,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Medicinova Inc | Kazuko Matsuda | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2026 | 350,000 | 350,000 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2024 | 157,500 | 157,500 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2023 | 149,625 | 149,625 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 192,500 | 192,500 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 60,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.30 per share. | 23 Aug 2021 | 60,000 | 322,996 (0%) | 0% | 2.3 | 138,000 | Common Stock |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2021 | 56,250 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.46 per share. | 24 Jun 2021 | 56,250 | 262,996 (0%) | 0% | 2.5 | 138,375 | Common Stock |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.54 per share. | 24 Jun 2021 | 46,554 | 206,746 (0%) | 0% | 2.5 | 118,247 | Common Stock |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2021 | 46,554 | 0 | - | - | Employee Stock Option (Right to Buy) |